13-May-2024
No headlines found.
Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
Globe Newswire (Wed, 1-May 4:05 PM ET)
Corcept Completes Enrollment in Phase 4 CATALYST Trial
Globe Newswire (Mon, 29-Apr 8:00 AM ET)
Globe Newswire (Wed, 24-Apr 4:05 PM ET)
Globe Newswire (Mon, 22-Apr 8:00 AM ET)
Globe Newswire (Mon, 15-Apr 8:00 AM ET)
Globe Newswire (Mon, 8-Apr 8:00 AM ET)
Globe Newswire (Mon, 1-Apr 8:00 AM ET)
Globe Newswire (Thu, 15-Feb 4:07 PM ET)
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial
Globe Newswire (Thu, 15-Feb 4:02 PM ET)
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
Corcept Therapeutics trades on the NASDAQ stock market under the symbol CORT.
As of May 13, 2024, CORT stock price climbed to $27.53 with 1,693,991 million shares trading.
CORT has a beta of 0.77, meaning it tends to be less sensitive to market movements. CORT has a correlation of 0.03 to the broad based SPY ETF.
CORT has a market cap of $2.86 billion. This is considered a Mid Cap stock.
Last quarter Corcept Therapeutics reported $147 million in Revenue and $.25 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.03.
In the last 3 years, CORT stock traded as high as $34.28 and as low as $15.83.
The top ETF exchange traded funds that CORT belongs to (by Net Assets): IJR, VTI, VB, IWM, FBT.
CORT stock has underperformed the market in the last year with a return of +14.7%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CORT shares. However, CORT has outperformed the market in the last 3 month and 2 week periods, returning +19.6% and +20.7%, while SPY returned +4.3% and +2.5%, respectively. This indicates CORT has been having a stronger performance recently.
CORT support price is $26.13 and resistance is $27.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CORT stock will trade within this expected range on the day.